# PROPOFOL
> **ANDA217013** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2024-06-20
## Drug
- **FDA Application Number:** ANDA217013
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PROPOFOL
- **Generic name:** Propofol
- **Active ingredients:** PROPOFOL
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **First approval:** 2024-06-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217013)
---
*MORVS · CC0 1.0*